New Medicines Globally
Every day, medicine access delays cost lives.
Medicine access. Made simple.
We guide you through the process of safely and legally accessing a new medicine that is not available where you live.
Find the latest medicines in neurology, oncology and rare diseases.
Thousands of patients helped from 175 countries. Let us help you.
We have helped patients from all over the world access new medicines for life debilitating illnesses. View our live map to see the countries we have served to date.
Latest approved medicines available.
Hereditary Angioedema | Orladeyo (berotralstat) by BioCryst - Approved by the FDA December 2020.
Sickle-Cell Disease | Adakveo (crizanlizumab) by Novartis - Approved by the FDA November 2019.
Primary Hyperoxaluria type 1 | Oxlumo (lumasiran) by Alnylam Pharmaceuticals - Approved by the EMA and FDA November 2020.
Neuroblastoma| Danyelza (naxitamab-gqgk) by Y-mAbs Therapeutics - Approved by the FDA November 2020.